Beta Bionics' flagship product, the iLet Bionic Pancreas, is an autonomous insulin delivery system that streamlines diabetes management and reduces the burden on patients and physicians. The iLet will ...
The following is the third part of a series on brain-machine integration and biomechanical solutions to restore function to tissues damaged by disease, trauma, or time. The FDA recently granted ...
“As the first fully automated insulin dosing system, the iLet changes the paradigm of diabetes management,” said Beta Bionics CEO Sean Saint. “By eliminating traditional setup, carb counting and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results